Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Resignation of Managing Director/CEO

July 21, 2025

Trump’s Nuclear Revival Plan Boosts Uranium Prices, Sends...

May 30, 2025

Crypto Market Recap: Trump Signs First Crypto Bill,...

April 12, 2025

Lupin Protein Health Benefits Presentation

March 24, 2025

Athena Gold Upsizes Flow-Through Private Placement, Announces Concurrent...

April 22, 2025

High Grade surface silver results up to 920g/t...

May 15, 2025

2025 Crypto Market: Q2 Review and Forecast

July 9, 2025

Barrick Backs Hercules in Leviathan-Linked Copper Expansion

July 29, 2025

Top 5 Canadian Mining Stocks This Week: St....

June 14, 2025

Empire Metals Limited Announces Major Drilling Campaign Targeting...

June 3, 2025